BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 29982424)

  • 1. Localizing parkinsonism based on focal brain lesions.
    Joutsa J; Horn A; Hsu J; Fox MD
    Brain; 2018 Aug; 141(8):2445-2456. PubMed ID: 29982424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor.
    Prodoehl J; Li H; Planetta PJ; Goetz CG; Shannon KM; Tangonan R; Comella CL; Simuni T; Zhou XJ; Leurgans S; Corcos DM; Vaillancourt DE
    Mov Disord; 2013 Nov; 28(13):1816-22. PubMed ID: 23674400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network localization of cervical dystonia based on causal brain lesions.
    Corp DT; Joutsa J; Darby RR; Delnooz CCS; van de Warrenburg BPC; Cooke D; Prudente CN; Ren J; Reich MM; Batla A; Bhatia KP; Jinnah HA; Liu H; Fox MD
    Brain; 2019 Jun; 142(6):1660-1674. PubMed ID: 31099831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal alterations of the basal ganglia in the differential diagnosis of Parkinson's disease: a retrospective case-controlled MRI data bank analysis.
    Jesse S; Kassubek J; Müller HP; Ludolph AC; Unrath A
    BMC Neurol; 2012 Dec; 12():163. PubMed ID: 23273141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A differential diagnosis of Parkinsonism.
    Weiner WJ
    Rev Neurol Dis; 2005; 2(3):124-31. PubMed ID: 16400311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
    Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
    No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
    Lehéricy S; Hartmann A; Lannuzel A; Galanaud D; Delmaire C; Bienaimée MJ; Jodoin N; Roze E; Gaymard B; Vidailhet M
    Brain; 2010 Aug; 133(Pt 8):2410-25. PubMed ID: 20826434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cerebral Network of Parkinson's Tremor: An Effective Connectivity fMRI Study.
    Dirkx MF; den Ouden H; Aarts E; Timmer M; Bloem BR; Toni I; Helmich RC
    J Neurosci; 2016 May; 36(19):5362-72. PubMed ID: 27170132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain perfusion differences in parkinsonian disorders.
    Kimura N; Hanaki S; Masuda T; Hanaoka T; Hazama Y; Okazaki T; Arakawa R; Kumamoto T
    Mov Disord; 2011 Dec; 26(14):2530-7. PubMed ID: 21830234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of thalamic intralaminar nuclei in progressive supranuclear palsy and Parkinson's disease: clinical and therapeutic implications.
    Henderson JM; Carpenter K; Cartwright H; Halliday GM
    Brain; 2000 Jul; 123 ( Pt 7)():1410-21. PubMed ID: 10869053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
    Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
    Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.
    Hauser MA; Li YJ; Xu H; Noureddine MA; Shao YS; Gullans SR; Scherzer CR; Jensen RV; McLaurin AC; Gibson JR; Scott BL; Jewett RM; Stenger JE; Schmechel DE; Hulette CM; Vance JM
    Arch Neurol; 2005 Jun; 62(6):917-21. PubMed ID: 15956162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical correlates of similar pathologies in parkinsonian syndromes.
    Song YJ; Huang Y; Halliday GM
    Mov Disord; 2011 Feb; 26(3):499-506. PubMed ID: 21259341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathology of Parkinson's disease and related syndromes.
    Gibb WR
    Neurol Clin; 1992 May; 10(2):361-76. PubMed ID: 1584179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease.
    Hardman CD; Halliday GM
    Exp Neurol; 1999 Jul; 158(1):135-42. PubMed ID: 10448425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Connectome in Parkinson's Disease and Parkinsonism.
    Tinaz S
    Curr Neurol Neurosci Rep; 2021 Apr; 21(6):24. PubMed ID: 33817766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
    Juh R; Kim J; Moon D; Choe B; Suh T
    Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.